Alpha IVF Group Berhad (KLSE:ALPHA)

Market Cap	1.21B -11.1%
Revenue (ttm)	196.52M +13.2%
Net Income	55.80M +0.7%
EPS	0.01 +0.9%
Shares Out	4.84B
PE Ratio	21.82
Forward PE	21.74
Dividend	0.01 (4.00%)
Ex-Dividend Date	Mar 18, 2026

Volume	2,746,000
Average Volume	1,964,870
Open	0.2500
Previous Close	0.2500
Day's Range	0.2450 - 0.2550
52-Week Range	0.2500 - 0.3450
Beta	0.31
RSI	34.17
Earnings Date	Jul 17, 2026

About Alpha IVF Group Berhad

Alpha IVF Group Berhad, together with its subsidiaries, operates as a fertility care specialist that focuses on the provision of assisted reproductive services in Malaysia, Singapore, Indonesia, China, Middle East, the Philippines, and internationally. The company offers assisted reproductive treatment services comprising ovulation induction, intra-uterine insemination, in-vitro fertilization treatment, intra-cytoplasmic sperm injection, gamete intrafallopian transfer, and savior sibling program; preimplantation genetic testing; implantation op...

• Industry: Offices and Clinics of Doctors of Medicine
• Founded: 2011
• Employees: 198
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: ALPHA

Financial Performance

In fiscal year 2025, Alpha IVF Group Berhad's revenue was 176.84 million, an increase of 5.52% compared to the previous year's 167.59 million. Earnings were 57.45 million, an increase of 8.54%.